概括
在子宫内接触到狂喜药 (MDMA) 可能会增加新生儿的先天性缺陷风险. 这项前性研究发现,暴露的婴儿心血管和肌肉骨异常的发病率更高.
科学领域:
- 围产儿医学 围产儿医学
- 发育毒理学 发展毒理学
- 产科 产科 产科 产科 产科
背景情况:
- 研究娱乐性药物使用对胎儿发育的子宫内影响对于了解潜在的健康风险至关重要.
- 狂喜药 (3,4-甲基二氧化甲胺) 是一种广泛使用的娱乐性药物,其长期发育影响尚不清楚.
- 这项研究前性地跟踪了在怀孕期间接触到ecstasy的婴儿.
更多相关视频
15:27Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
相关概念视频
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...